SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.110-1.4%Nov 6 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bobbseytwins2001 who wrote (1049)5/29/2025 4:25:37 PM
From: jargonweary2 Recommendations

Recommended By
Fitzhughlaw
rodneyh07

  Read Replies (1) of 1229
 
My experience is considerably less than yours but I also don’t understand how shorting this stock at this price makes sense. If the stock was selling around 8-10 I guess I could understand how a short investor might want to gamble on the stock going under 2 on bad news. But the stock continues to trade under 3 and for all of the reasonable doubts and concerns one might have about PSS the company does have an approved drug with decent if not great revenues and the strong possibility of approvals for it in other markets around the world. So the risk/reward of the short position here makes no sense to me, either.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News